Elizabeth de Lange (PhD) is Professor in Predictive Pharmacology and Principal Investigator in the Research Division Systems Biomedicine and Pharmacology, Leiden Academic Center for Drug Research (LACDR), at Leiden University.
Her ambition to increase the efficiency of the drug development process, by contributing to unravel mechanisms which determine target site pharmacokinetics (PK) and related pharmacodynamics (PD), motivated Elizabeth to support QTM as Chair of the Scientific Advisory Board.
Elizabeth previously worked on: